Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Report on Extraordinary General Meeting of NeuroSearch A/S


Posted on: 14 Sep 18

Announcement
14 September 2018



At the company’s Extraordinary General Meeting held today, the following resolution was passed:

Morten Mathiesen and Mikkel Primdal Kæregaard were elected to the Board of Directors. Karin Garre and Christian Lundgren resigned.

After the General Meeting the Board of Directors has elected Mikkel Primdal Kæregaard as chairman and Morten Mathiesen as vice chairman. The Board of Directors thus consists of Mikkel Primdal Kæregaard (chairman), Morten Mathiesen (vice chairman) and Allan Andersen.



Allan Andersen
CEO



Contact
Allan Andersen, CEO, mobile phone +45 4016 3864.



About NeuroSearch
NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.

Attachment

GlobeNewswire
globenewswire.com

Last updated on: 14/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.